ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,133, issued on Oct. 20, was assigned to Biohaven Therapeutics Ltd. (New Haven, Conn.).

"Compositions and methods for treating obsessive-compulsive disorder" was invented by Vladimir Coric (Madison, Conn.), Robert Berman (New Haven, Conn.) and Loren Aguiar (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a method for treating obsessive-compulsive disorder in a patient in need thereof by administering to the patient a dosage form including an effective amount of troriluzole."

The patent was filed on June 24, 2021, under Application No. 17/923,587.

*For further information, including images, charts and tables, plea...